Anavex Life Sciences Corp.
AVXL • NASDAQ • Stock Fundamentals
Anavex Life Sciences Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher U. Missling, with a market cap of $251.1M.
Market Cap$251.1M
Employees40.0
CEOChristopher U. Missling
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsFeb 9, 2026 · 3 months 19 days agoQ4 2025
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q4 2025 filing
Anavex Life Sciences Corp. FAQ
Common questions about Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL) has a market capitalization of $251.1M and trades on NASDAQ.
Anavex Life Sciences Corp. has approximately 40 employees.